Erlotinib and Proton Therapy for Locally Advanced Pancreatic Cancer: A Phase II Trial

Purpose/Objective(s): Epidermal growth factor receptor (EGFR) is overexpressed in pancreatic cancer. EGFR expression plays a potentially important role in modulation of tumor sensitivity to either chemotherapy or radiotherapy. Erlotinib is a receptor...